Durable natural killer cell responses after heterologous two-dose Ebola vaccination

Natural killer (NK) cells are implicated among immune effectors after vaccination against viral pathogens, including Ebola virus. The two-dose heterologous Ebola virus vaccine regimen, adenovirus type 26.ZEBOV followed by modified vaccinia Ankara-BN-Filo (EBOVAC2 consortium, EU Innovative Medicines...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagstaffe, Helen R., Susannini, Giada, Thiébaut, Rodolphe, Richert, Laura, Lévy, Yves, Bockstal, Viki, Stoop, Jeroen N., Luhn, Kerstin, Douoguih, Macaya, Riley, Eleanor M., Lacabaratz, Christine, Goodier, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846750/
https://www.ncbi.nlm.nih.gov/pubmed/33514756
http://dx.doi.org/10.1038/s41541-021-00280-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846750/
https://www.ncbi.nlm.nih.gov/pubmed/33514756
http://dx.doi.org/10.1038/s41541-021-00280-0

Ejemplares similares